Aadi Bioscience, Inc. (NASDAQ:AADI) Q3 2022 Earnings Conference Call November 9, 2022 8:30 AM ET

Company Participants

Marcy Graham - Senior Vice President of Investor Relations & Corporate Communications

Neil Desai - President & Chief Executive Officer

Brendan Delaney - Chief Operating Officer

Loretta Itri - Chief Medical Officer

Scott Giacobello - Chief Financial Officer

Conference Call Participants

Roger Song - Jefferies

Boris Peaker - Cowen

Joseph Catanzaro - Piper Sandler

Operator

Good day and thank you for standing by. Welcome to the Aadi Bioscience, Inc. Third Quarter Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

I would like to hand the conference over to your host today, Marcy Graham, Senior Vice President, Investor Relations and Corporate Communications.

Marcy Graham

Good morning and welcome to the Aadi Bioscience conference call to review results of and provide an update on the third quarter of 2022. Joining me on the call today is our Founder and CEO, Neil Desai, who will provide an overview of activity during the quarter, followed by Brendan Delaney, our Chief Operating Officer, who will give us an update on our early commercial progress. Next will be our Chief Medical Officer, Dr. Loretta Itri, who will give us a brief update on our clinical progress; followed by our CFO, Scott Giacobello, with a review of our financial performance during the period. We will open the line for questions at the end of the call following closing comments.

Before we get started, a quick reminder that statements made on the call today will include forward-looking statements. Actual events or results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors, including those set forth in the Risk Factors section of our annual and quarterly filings with the Securities and Exchange Commission which can be found at www.sec.gov or on our website at www.aadibio.com. In addition, any forward-looking statements made on this call represent our views only as of today, November 9, 2022 and should not be relied upon as representing our views as of any subsequent date. We specifically disclaim any obligation to update or revise any forward-looking statements.

With that, I will turn the call over to Neil for his opening statements. Neil?

Neil Desai

Thank you, Marcy. Good morning, everyone and thank you for joining us today for the earnings results call for the third quarter of 2022.